Elicio Therapeutics (ELTX) Shares Issued (2020 - 2026)
Elicio Therapeutics posted quarterly Shares Issued of $100000.0 for Q1 2026, down 70.85% year-on-year from $343000.0 in Q1 2025, and down 99.33% on a QoQ basis from $15.0 million in Q4 2025.
Elicio Therapeutics (ELTX) has 7 years of Shares Issued data on file, last reported at $100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued fell 70.85% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $16.0 million (up 384.82% YoY), and the FY2025 full-year result was $16.2 million, up 41551.28% from the prior year.
- Shares Issued for Q1 2026 stood at $100000.0, down from $15.0 million in the prior quarter.
- Across five years, Shares Issued topped out at $15.0 million in Q4 2025 and bottomed at -$5.4 million in Q3 2024.
- The 5-year median for Shares Issued is $89000.0 (2022), against an average of $1.7 million.
- The widest annual swing landed in 2024, when Shares Issued slumped 4324.41%; it then surged 38235.9% in 2025.
- A 5-year view of Shares Issued shows it stood at $65000.0 in 2022, then surged by 10472.31% to $6.9 million in 2023, then sank by 99.43% to $39000.0 in 2024, then soared by 38235.9% to $15.0 million in 2025, then plunged by 99.33% to $100000.0 in 2026.
- The last three Shares Issued figures came in at $100000.0 (Q1 2026), $15.0 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 14.95 Mn |
| Dec 31, 2025 | 14.95 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | -286,000.00 |
| Jun 30, 2025 | -286,000.00 |
| Mar 31, 2025 | 343,000.00 |
| Mar 31, 2025 | 343,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Sep 30, 2024 | -5.37 Mn |
| Sep 30, 2024 | -5.37 Mn |
| Jun 30, 2024 | -635,000.00 |
| Jun 30, 2024 | -635,000.00 |
| Mar 31, 2024 | 6.00 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | 6.87 Mn |
| Dec 31, 2023 | 6.87 Mn |
| Sep 30, 2023 | 127,000.00 |
| Sep 30, 2023 | 127,000.00 |
| Dec 31, 2022 | 65,000.00 |
| Dec 31, 2022 | 65,000.00 |
| Sep 30, 2022 | -61,000.00 |
| Sep 30, 2022 | -61,000.00 |
| Jun 30, 2022 | 78,000.00 |
| Jun 30, 2022 | 78,000.00 |
| Dec 31, 2021 | 107.47 Mn |
| Dec 31, 2021 | 107.47 Mn |
| Sep 30, 2021 | -59,000.00 |
| Sep 30, 2021 | -59,000.00 |
| Jun 30, 2021 | -110.48 Mn |
| Jun 30, 2021 | -110.48 Mn |
| Mar 31, 2021 | 110.56 Mn |
| Mar 31, 2021 | 110.56 Mn |
| Dec 31, 2020 | 713,000.00 |
| Dec 31, 2020 | 713,000.00 |
| Sep 30, 2020 | 38,000.00 |
| Sep 30, 2020 | 38,000.00 |
| Jun 30, 2020 | -1,000.00 |
| Jun 30, 2020 | -1,000.00 |
| Mar 31, 2020 | 1,000.00 |
| Mar 31, 2020 | 1,000.00 |